Tirzepatide TR60 60mg*10vials

Product Description

Tirzepatide 60mg × 10 vials is an ultra-high titer, research-only dual-receptor peptide optimized for cutting-edge biomedical and metabolic mechanism research. As a potent dual agonist of GLP-1 and GIP receptors, Tirzepatide is a core, cutting-edge research tool for studying systemic energy metabolism, appetite regulation, lipid turnover efficiency, and complex metabolic signaling pathways. It is widely used in academic laboratory research, drug mechanism analysis, and high-standard commercial experimental projects.

This product uses a superior 60mg ultra-high concentration formulation, outperforming traditional 10mg, 15mg, 30mg, 40mg, and 50mg Tirzepatide specifications. The higher concentration of active peptide significantly reduces repeated dilutions, minimizing human experimental error and the risk of cross-contamination, and resulting in more significant and measurable biological responses. This product is perfectly suited for high-dose experimental protocols, large-scale batch testing, long-term continuous studies, and high-sensitivity data validation, helping researchers obtain more stable, reproducible, and authoritative experimental results.

This product is manufactured using advanced vacuum freeze-drying technology, which fully preserves the molecular structure of the peptides, effectively preventing degradation and ensuring ultra-high purity, excellent solubility, and superior chemical stability. Each batch undergoes rigorous testing by a third-party laboratory and comes with a standard Certificate of Account (COA), meeting global laboratory quality control requirements. Each set contains 10 individual sterile sealed vials, supporting flexible batch use, categorized storage, and standardized experimental management, fully meeting the needs of high-intensity, long-term research in professional biomedical laboratories and research institutions.

Key Advantages (Research Applications)

- Dual-target activation of GLP-1 and GIP receptors, supporting in-depth research into metabolic regulation, energy expenditure, appetite physiology, and lipid metabolism mechanisms.

- Ultra-high concentration (60mg) design, perfectly suited for high-dose experimental protocols, simplifying dilution procedures and significantly improving experimental accuracy and data stability.

- Suitable for advanced research such as metabolic homeostasis, body composition regulation, metabolic physiological changes, and exploration of related biomedical mechanisms.

- Highly stable lyophilized powder, rapid reconstitution, easy to transport and long-term low-temperature storage, maintaining stable molecular activity.

- Completed batch testing and official COA certification, ensuring consistent high purity and reliable experimental data for academic and commercial laboratory research.

Ultra-high concentration tezoparatide 60mg 10 vials lyophilized research peptide. Dual-target GLP-1 and GIP receptor agonist, high purity, with complete COA certification.